114 related articles for article (PubMed ID: 12612387)
41. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
[TBL] [Abstract][Full Text] [Related]
42. [Comparative evaluation of 2 non-ionic contrast media, iopentol (350 mgI/ml) and iopamidol (370 mgI/ml) in coronary angiography].
Maddestra N; Di Cesare A; Salute L; Toppetti A; Minguzzi P; Marelli C; Bonomo L
Radiol Med; 1994 Oct; 88(4):396-400. PubMed ID: 7997610
[TBL] [Abstract][Full Text] [Related]
43. The effects of iodixanol and iopamidol on hemodynamic and cardiac electrophysiologic parameters in vitro and in vivo.
Dundore RL; Silver PJ; Ezrin AM; Lee KC; Buchholz RA; van Aller G; Clas DM; Roth GM; Harnish PP; Bailey DM
Invest Radiol; 1991 Aug; 26(8):715-21. PubMed ID: 1917406
[TBL] [Abstract][Full Text] [Related]
44. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
Lasser EC; Lyon SG; Berry CC
Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
[TBL] [Abstract][Full Text] [Related]
45. Streak artefacts in Computed Tomography Urography: Comparative evaluation between two different iodinated contrast media.
Pedote P; Cozzolino M; Nicolardi M; Accogli RU; Sardaro A; Scardapane A; Stabile Ianora AA
J Med Imaging Radiat Oncol; 2022 Oct; 66(7):940-945. PubMed ID: 34854240
[TBL] [Abstract][Full Text] [Related]
46. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
Schmiedel E
Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
[TBL] [Abstract][Full Text] [Related]
47. [Tolerability of nonionic contrast media--results of a multicenter double blind study].
Schmiedel E
Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929
[TBL] [Abstract][Full Text] [Related]
48. A comparison of iodixanol with iopamidol in aorto-femoral angiography.
Verow P; Nossen JO; Sheppick A; Kjaersgaard P
Br J Radiol; 1995 Sep; 68(813):973-8. PubMed ID: 7496696
[TBL] [Abstract][Full Text] [Related]
49. A randomized, double-blind, parallel group trial of iomeprol, iohexol and iopamidol in intravenous urography.
Harding JR; Bertazzoli M; Spinazzi A
Br J Radiol; 1995 Jul; 68(811):712-5. PubMed ID: 7640924
[TBL] [Abstract][Full Text] [Related]
50. [Iomeprol: results of clinical trials with a new nonionic contrast medium in children].
van Gessel R; Möller A; Schmiedel E
Aktuelle Radiol; 1994 Sep; 4(5):225-8. PubMed ID: 7986838
[TBL] [Abstract][Full Text] [Related]
51. Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.
Watanabe H; Sueki H; Nakada T; Akiyama M; Iijima M
Dermatology; 1999; 198(3):291-4. PubMed ID: 10393456
[TBL] [Abstract][Full Text] [Related]
52. Non-immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross-reactivity with other iodinated contrast media.
Gamboa P; Sánchez de Vicente J; Galán C; Jáuregui I; Segurola A; García-Lirio E; Seras Y; Martínez-Antón MD; Arrien de Lecea A
Allergy; 2022 Dec; 77(12):3641-3647. PubMed ID: 35815908
[TBL] [Abstract][Full Text] [Related]
53. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
54. Peripheral arteriography with a new nonionic agent: comparison of iomeprol with iopamidol.
Ugolotti U; Larini P; Marcato C; Cusmano F; Puccianti F
Eur J Radiol; 1994 May; 18 Suppl 1():S77-82. PubMed ID: 8020523
[TBL] [Abstract][Full Text] [Related]
55. Image quality and safety after iodixanol in intravenous urography; a comparison with iohexol.
Sundgren PC; Bååth L; Törnquist C; Hougens Grynne B; Kjaersgaard P; Almén T
Br J Radiol; 1996 Aug; 69(824):699-703. PubMed ID: 8949670
[TBL] [Abstract][Full Text] [Related]
56. Assessment of the side-effects of iomeprol.
Katayama H; Kozuka T; Ebata K
Eur J Radiol; 1994 May; 18 Suppl 1():S115-9. PubMed ID: 8020513
[TBL] [Abstract][Full Text] [Related]
57. Influence of radiographic contrast media (Iodixanol and Iomeprol) on the endothelin-1 release from human arterial and venous endothelial cells cultured on an extracellular matrix.
Franke RP; Fuhrmann R; Hiebl B; Jung F
Clin Hemorheol Microcirc; 2012; 52(2-4):229-34. PubMed ID: 22975938
[TBL] [Abstract][Full Text] [Related]
58. Late skin reaction to iodixanol (Visipaque): clinical manifestations, patch test study, and histopathological evaluation.
Delgado-Jimenez Y; Perez-Gala S; Aragüés M; Sanchez-Perez J; Garcia-Diez A
Contact Dermatitis; 2006 Dec; 55(6):348-53. PubMed ID: 17101010
[TBL] [Abstract][Full Text] [Related]
59. Iomeprol vs iopamidol in intraarterial peripheral digital subtraction angiography.
Dacoronias D; Minguzzi P; Ugolotti U; Dettori AG
Angiology; 1992 Sep; 43(9):734-40. PubMed ID: 1514709
[TBL] [Abstract][Full Text] [Related]
60. Neural tolerance of the non-ionic dimers iodixanol and iotrolan and the non-ionic monomer iopamidol during myelography in non-anaesthetised rabbits.
Maly P; Sundgren P; Bååth L; Walday P
Acta Radiol; 1995 Nov; 36(6):644-8. PubMed ID: 8519577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
